Nothing Special   »   [go: up one dir, main page]

Huse et al., 1992 - Google Patents

Application of a filamentous phage pVIII fusion protein system suitable for efficient production, screening, and mutagenesis of F (ab) antibody fragments.

Huse et al., 1992

View PDF
Document ID
7175176005842164902
Author
Huse W
Stinchcombe T
Glaser S
Starr L
MacLean M
Hellström K
Hellström I
Yelton D
Publication year
Publication venue
Journal of immunology (Baltimore, Md.: 1950)

External Links

Snippet

We describe the application of a novel filamentous phage vector system suitable for efficient screening and production of F (ab) antibody fragments. The vector system can concurrently produce free F (ab) fragments and F (ab) displayed on the surface of M13 bacteriophage via …
Continue reading at scholar.archive.org (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL CHEMISTRY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICO LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by micro-organisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only micro-organisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin

Similar Documents

Publication Publication Date Title
Huse et al. Application of a filamentous phage pVIII fusion protein system suitable for efficient production, screening, and mutagenesis of F (ab) antibody fragments.
Crameri et al. Display of biologically active proteins on the surface of filamentous phages: a cDNA cloning system for selection of functional gene products linked to the genetic information responsible for their production
Qi et al. Phagemid vectors for phage display: properties, characteristics and construction
McCafferty et al. Selection and rapid purification of murine antibody fragments that bind a transition-state analog by phage display
AU691817B2 (en) Sbp members with a chemical moiety covalently bound within the binding site; production and selection thereof
Glaser et al. Antibody engineering by codon-based mutagenesis in a filamentous phage vector system.
DE69123156T2 (en) METHOD FOR GENERATING FUNCTIONAL, SINGLE-CHAIN Fv ANTIBODY FRAGMENTS ON BACTERIOPHAGE SURFACES
CA2109602C (en) Methods for producing members of specific binding pairs
US6916605B1 (en) Methods for producing members of specific binding pairs
EP0866136B1 (en) Recombinant library screening methods
Jostock et al. Rapid generation of functional human IgG antibodies derived from Fab-on-phage display libraries
US6172197B1 (en) Methods for producing members of specific binding pairs
Yau et al. Emerging trends in the synthesis and improvement of hapten-specific recombinant antibodies
US7063943B1 (en) Methods for producing members of specific binding pairs
Hogrefe et al. A bacteriophage lambda vector for the cloning and expression of immunoglobulin Fab fragments on the surface of filamentous phage
Cai et al. A melanoma-specific VH antibody cloned from a fusion phage library of a vaccinated melanoma patient.
Bradbury et al. Use of living columns to select specific phage antibodies
JP2002514919A (en) Multivalent and polyclonal libraries
Pini et al. Hierarchical affinity maturation of a phage library derived antibody for the selective removal of cytomegalovirus from plasma
US20060252028A1 (en) Method of assaying interaction between proteins
Oh et al. Enhancing phage display of antibody fragments using gIII-amber suppression
Hogrefe et al. Cloning in a bacteriophage lambda vector for the display of binding proteins on filamentous phage
Mersmann et al. Monitoring of scFv selected by phage display using detection of scFv–pIII fusion proteins in a microtiter scale assay
KR100458083B1 (en) Method for the construction of phage display library using helper phage variants
Rohrbach et al. Antibody Phage Display Libraries for Use in Therapeutic Gene Targeting